// App-Quantinova.ai

42 : Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era

Researchers

Presenter

  • K. Lentine

Principal Investigators

  • D. Axelrod

  • R. Bloom

  • H. Xiao

  • D. Segev

  • T. Alhamad

  • H. Randall

  • R. Ouseph

  • V. Dharnidharka

  • D. Brennan

  • N. Lam

  • A. Naik

  • G. Hess

  • B. Kaiske

  • M. Schnitzler

Medical Centers

  • Saint Louis Uni., St. Louis

  • Lahey, Burlington

  • CHOP/U Penn, Philadelphia, PA.

  • Johns Hopkins, Baltimore, MD

  • Washington Univ., Saint Louis, MO.

  • University of Alberta, Edmonton, AB, Canada

  • U Michigan, Ann Arbor, MI

  • Hennepin, Minneapolis

  • Symphony Health, Conshohocken, PA.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • Sofosbuvir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved